Literature DB >> 6861373

IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis.

K B Elkon, A E Gharavi, B M Patel, G R Hughes, A Frankel.   

Abstract

Paired serum and saliva samples from seven patients with systemic sicca syndrome (SSS), 15 patients with rheumatoid arthritis and a positive Schirmer's test (RA+), 15 patients with rheumatoid arthritis and negative Schirmer's test (RA-) and 14 normal individuals were analysed for albumin and immunoglobulin concentration as well as IgA and IgM rheumatoid factor (RF) activity. Protein levels in saliva were higher in SSS and RA+ but, when corrected for serum concentration and salivary flow rate, only the IgG ratio remained significantly elevated in SSS (P less than 0.01) and RA- (P less than 0.05) and the IgM ratio was reduced in RA- (P less than 0.05) compared to controls. Although IgM RF activity in serum and saliva was strongly correlated (P less than 0.001) in all three patient groups, the activity in saliva was considerably lower than serum activity. In the two (RA) patients tested, IgM RF in saliva contained secretory component. Mean salivary IgA RF activity varied between 34% (RA-) and 84% (SSS) of serum activity and correlated with serum activity in SSS (P less than 0.001) and RA- (P less than 0.01). IgA RFs in saliva, but not in serum, contained secretory component. Additional demonstration of IgA RF activity in nasal and duodenal secretions in SSS may be related to involvement of the common mucosal immune system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861373      PMCID: PMC1535585     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Bronchial lymphoid tissue. I. Morphologic characteristics.

Authors:  J Bienenstock; N Johnston; D Y Perey
Journal:  Lab Invest       Date:  1973-06       Impact factor: 5.662

3.  Salivary immunoglobulins in Sjögren's syndrome.

Authors:  R Bluestone; J M Gumpel; L S Goldberg; E J Holborow
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

4.  Immunoglobulin D in serum, body fluids and lymphoid tissues.

Authors:  D S Rowe; P A Crabbé; M W Turner
Journal:  Clin Exp Immunol       Date:  1968-07       Impact factor: 4.330

5.  Urinary gammaA rheumatoid factor.

Authors:  J Bienenstock; G Goldstein; T B Tomasi
Journal:  J Lab Clin Med       Date:  1969-03

6.  Distribution of the anti-gamma globulin factors in the synovial membrane and other tissues in various diseases.

Authors:  L Bonomo; A Tursi; U Gillardi
Journal:  Ann Rheum Dis       Date:  1968-03       Impact factor: 19.103

7.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

8.  Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment.

Authors:  L G Anderson; N A Cummings; R Asofsky; M B Hylton; T M Tarpley; T B Tomasi; R O Wolf; G L Schall; N Talal
Journal:  Am J Med       Date:  1972-10       Impact factor: 4.965

9.  The quantitation of rheumatoid factors.

Authors:  D J Lea; D J Ward
Journal:  Arthritis Rheum       Date:  1972 Nov-Dec

10.  The relation of human salivary gamma A globulin and albumin to flow rate.

Authors:  I D Mandel; H S Khurana
Journal:  Arch Oral Biol       Date:  1969-12       Impact factor: 2.633

View more
  24 in total

1.  The specificity of antiglobulin autoantibodies in patients with primary Sjögren's syndrome.

Authors:  T Wada; I Ezaki; M Shingu; S Nonaka; E Ohtsuka; M Yasuda; M Nobunaga
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

2.  Significance of rheumatoid factors in an eight-year longitudinal study on arthritis.

Authors:  T Tuomi; K Aho; T Palosuo; K Kaarela; R von Essen; H Isomäki; M Leirisalo-Repo; S Sarna
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

3.  Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.

Authors:  P Bini; J L Chu; C Okolo; K Elkon
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

4.  A human monoclonal IgA rheumatoid factor using the VkIV light chain gene.

Authors:  R Mierau; A Gause; R Küppers; M Michels; R A Mageed; R Jefferis; E Genth
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

5.  Thyrotropin receptor antibodies in parotid saliva.

Authors:  O R Tumilasci; M C Arqueros; M A Ostuni; E el Tamer; A B Houssay
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

6.  Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome.

Authors:  E Ben-Chetrit; R Fischel; A Rubinow
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

7.  Common IgA and IgM rheumatoid factor idiotypes in autoimmune diseases.

Authors:  A E Gharavi; B M Patel; G R Hughes; K B Elkon
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

8.  The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.

Authors:  J Drappa; N Brot; K B Elkon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis.

Authors:  M Gioud-Paquet; M Auvinet; T Raffin; P Girard; M Bouvier; E Lejeune; J C Monier
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

10.  Hormonal influence on the secretory immune system of the eye: androgen control of secretory component production by the rat exorbital gland.

Authors:  D A Sullivan; K J Bloch; M R Allansmith
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.